This is a Validated Antibody Database (VAD) review about pig ACTG2, based on 9 published articles (read how Labome selects the articles), using ACTG2 antibody in all methods. It is aimed to help Labome visitors find the most suited ACTG2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ACTG2 synonym: actin, gamma-enteric smooth muscle

Invitrogen
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:1000; loading ...; fig 2e
In order to study the involvement of RNase III nucleases in antiviral systems, Invitrogen ACTG2 antibody (Thermo Fisher, MS-1295-P) was used in western blot on human samples at 1:1000 (fig 2e). Nature (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; baker's yeast; fig 2c
In order to report that Lpl1 as a target of the Rpn4 response, Invitrogen ACTG2 antibody (ThermoFisher, MA511866) was used in western blot on baker's yeast samples (fig 2c). Mol Biol Cell (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; zebrafish ; 1:5000; loading ...; fig s2e
In order to propose that neurodevelopmental disorders and brain tumors may arise from changes in oncogenes, Invitrogen ACTG2 antibody (Neomarkers, ACTN05) was used in western blot on zebrafish samples at 1:5000 (fig s2e). Dis Model Mech (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; loading ...; fig 5g
In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen ACTG2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 5g). J Cell Physiol (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:300; fig 2
In order to study CD133+ subpopulations in pancreatic cancer, Invitrogen ACTG2 antibody (Thermo Fisher Scientific, Ab-5) was used in western blot on human samples at 1:300 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 3b
In order to screen for deubiquitinase inhibitors that prevent infection of macrophages by intracellular pathogens, Invitrogen ACTG2 antibody (Thermo Scientific, ACTN05) was used in western blot on mouse samples (fig 3b). Antimicrob Agents Chemother (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:3000; fig 3
  • western blot; mouse; 1:3000; fig 1
In order to investigate the PTHrP-cAMP-CREB1 axis in osteosarcoma, Invitrogen ACTG2 antibody (Thermo Scientific, Ab-5) was used in western blot on human samples at 1:3000 (fig 3) and in western blot on mouse samples at 1:3000 (fig 1). elife (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; dog; fig 8
In order to study how the role of increased caveolin-1 can help with repair to intervertebral disc degeneration, Invitrogen ACTG2 antibody (Neomarkers, pan Ab-5) was used in western blot on dog samples (fig 8). Arthritis Res Ther (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:10,000; fig 5
In order to show that sustained Zeb2 expression initiates T-cell leukemia, Invitrogen ACTG2 antibody (Molecular probes, C4) was used in western blot on human samples at 1:10,000 (fig 5). Nat Commun (2015) ncbi
Articles Reviewed
  1. Aguado L, Schmid S, May J, Sabin L, Panis M, Blanco Melo D, et al. RNase III nucleases from diverse kingdoms serve as antiviral effectors. Nature. 2017;547:114-117 pubmed publisher
  2. Weisshaar N, Welsch H, Guerra Moreno A, Hanna J. Phospholipase Lpl1 links lipid droplet function with quality control protein degradation. Mol Biol Cell. 2017;28:716-725 pubmed publisher
  3. Mayrhofer M, Gourain V, Reischl M, Affaticati P, Jenett A, Joly J, et al. A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth. Dis Model Mech. 2017;10:15-28 pubmed publisher
  4. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  5. Sousa A, Rei M, Freitas R, Ricardo S, Caffrey T, David L, et al. Effect of MUC1/?-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells. Oncol Lett. 2016;12:1811-1817 pubmed
  6. Passalacqua K, Charbonneau M, Donato N, Showalter H, Sun D, Wen B, et al. Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Antimicrob Agents Chemother. 2016;60:4183-96 pubmed publisher
  7. Walia M, Ho P, Taylor S, Ng A, Gupte A, Chalk A, et al. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. elife. 2016;5: pubmed publisher
  8. Bach F, Zhang Y, Miranda Bedate A, Verdonschot L, Bergknut N, Creemers L, et al. Increased caveolin-1 in intervertebral disc degeneration facilitates repair. Arthritis Res Ther. 2016;18:59 pubmed publisher
  9. Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794 pubmed publisher